These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 14729464)

  • 1. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing.
    Cheon SS; Nadesan P; Poon R; Alman BA
    Exp Cell Res; 2004 Feb; 293(2):267-74. PubMed ID: 14729464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds.
    Cheon S; Poon R; Yu C; Khoury M; Shenker R; Fish J; Alman BA
    Lab Invest; 2005 Mar; 85(3):416-25. PubMed ID: 15654359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt-independent beta-catenin transactivation in tumor development.
    Lu Z; Hunter T
    Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis.
    Edlund S; Lee SY; Grimsby S; Zhang S; Aspenström P; Heldin CH; Landström M
    Mol Cell Biol; 2005 Feb; 25(4):1475-88. PubMed ID: 15684397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation.
    DasGupta R; Fuchs E
    Development; 1999 Oct; 126(20):4557-68. PubMed ID: 10498690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
    Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
    J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
    Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
    Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.
    Cheon SS; Cheah AY; Turley S; Nadesan P; Poon R; Clevers H; Alman BA
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6973-8. PubMed ID: 11983872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).
    Clifford RL; Deacon K; Knox AJ
    J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling.
    Wang X; Xiao Y; Mou Y; Zhao Y; Blankesteijn WM; Hall JL
    Circ Res; 2002 Feb; 90(3):340-7. PubMed ID: 11861424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
    Zhang TF; Yu SQ; Guan LS; Wang ZY
    Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.
    Holnthoner W; Pillinger M; Groger M; Wolff K; Ashton AW; Albanese C; Neumeister P; Pestell RG; Petzelbauer P
    J Biol Chem; 2002 Nov; 277(48):45847-53. PubMed ID: 12235165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.
    Cervello M; Giannitrapani L; La Rosa M; Notarbartolo M; Labbozzetta M; Poma P; Montalto G; D'Alessandro N
    Int J Mol Med; 2004 May; 13(5):741-8. PubMed ID: 15067380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
    Liu J; Farmer SR
    J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.